Mochida Pharmaceutical
4534.T
#5902
Rank
โ‚ฌ0.79 B
Marketcap
22,53ย โ‚ฌ
Share price
2.13%
Change (1 day)
6.60%
Change (1 year)

P/E ratio for Mochida Pharmaceutical (4534.T)

P/E ratio as of December 2024 (TTM): 10.0

According to Mochida Pharmaceutical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.0058. At the end of 2024 the company had a P/E ratio of 25.2.

P/E ratio history for Mochida Pharmaceutical from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202425.236.63%
202318.532.39%
202214.0-29.19%
202119.7-49.42%
202039.040.8%
201927.768.14%
201816.5-16.07%
201719.6-4.65%
201620.6-1.3%
201520.836.11%
201415.318.35%
201312.914.08%
201211.3-44.02%
201120.396.76%
201010.3-20.3%
200912.9-2.21%
200813.2-43.04%
200723.2-21.3%
200629.5-27.49%
200540.6

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.